Baseline and First Trimester Uterine Artery Doppler Velocimetry to Predict Poor Obstetric Outcomes in IVF
The Effect of Baseline and First Trimester Uterine Artery Doppler Velocimetry Parameters on Obstetric Outcomes in HRT-FET Cycles: Prospective Cohort Study
1 other identifier
observational
500
1 country
1
Brief Summary
The researchers aim to determine how baseline (preconceptional) and first-trimester uterine artery Doppler measurements affect obstetric complications in women undergoing high-quality blastocyst transfer and to determine the correlation between the two Doppler measurements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2022
CompletedFirst Submitted
Initial submission to the registry
December 14, 2022
CompletedFirst Posted
Study publicly available on registry
December 22, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2024
CompletedMay 23, 2023
May 1, 2023
1.6 years
December 14, 2022
May 20, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Live Birth Rate
pregnancy beyond 24 weeks of gestational age.
9 months
Obstetric Complication Rates
Conditions such as preeclampsia, eclampsia, fetal growth restriction, oligohydramnios, polyhydramnios, preterm birth, gestational diabetes mellitus, antenatal bleeding and etc. that develop during pregnancy
20 weeks after embryo transfer
Study Arms (3)
non-pregnant
negative b-hCG results 9 days after embryo transfer.
pregnant with obstetric complications
Patients with a positive pregnancy result who develop obstetric complications such as preeclampsia, eclampsia, fetal growth restriction, oligohydramnios, polyhydramnios, preterm birth, gestational diabetes mellitus, antenatal bleeding and etc. after the 20th gestational weeks.
pregnant without obstetric complications
Patients who have positive pregnancy results and do not have any obstetric complications such as preeclampsia, eclampsia, fetal growth restriction, oligohydramnios, polyhydramnios, preterm birth, gestational diabetes mellitus, antenatal bleeding and etc. during pregnancy.
Interventions
The amount of resistance and blood flow in the main arteries that provide uterine perfusion will be determined by uterine artery Doppler velocimetry performed on the patients.
Eligibility Criteria
All patients who have artificial endometrial preparation with high-quality blastocysts between May 2022 and December 2022 will be included.
You may qualify if:
- Exogenous hormone preparation of the endometrial lining
- High embryo quality ((≥2BB) according to Alpha criteria
- Embryo transfer at the blastocyst stage
You may not qualify if:
- Patients whose treatments were canceled for any reason before the embryo transfer procedure
- Patients who underwent embryo transfer in the cleavage stage
- Presence of low-quality (\<2BB) blastocysts
- \>15% loss of viability of the embryo during embryo thawing,
- Patients with congenital uterine malformations,
- Patients in whom Doppler velocimetry cannot be performed optimally
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Akdeniz University
Antalya, 07700, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
ŞAFAK OLGAN, MD
Akdeniz University
- STUDY CHAIR
ARİF ÖZSİPAHİ, MD
Akdeniz University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 14, 2022
First Posted
December 22, 2022
Study Start
June 1, 2022
Primary Completion
January 1, 2024
Study Completion
April 15, 2024
Last Updated
May 23, 2023
Record last verified: 2023-05